SBIR/STTR Research Award

Commercialization of a phylogenetic cell separation method for downstream purification of nucleic acids

Award identifier 76480d4602a48a2a9ab34de1ba186bcaea1a79b6c9bb92f0e8e3323b0e627ed6Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$510,862

Program and phase

STTR · Phase II

Award year

2025

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
SYRACUSE BIOLABS, INC.
Proposal award date
2025-07-15
Contract end date
2027-06-30
UEI
QAW2G2NJY562
Solicitation number
PA23-232
Topic code
400

Research abstract

Abstract The success of all microbiome-based studies is highly dependent on effective sample purification of the target organisms of interest. Characterizing individual organismal components of these metagenomic samples relies heavily upon the ability to separate the individual phylogenetic components, such as removing human cells from the microbiological fraction while preventing sample loss or degradation. This Phase II STTR project aims to continue the development of and commercialize a patent pending simple and inexpensive purification approach aimed at effectively separating and preserving host and microbial DNA from a metagenomic sample. This method will ensure all organismal DNA is preserved (i.e., not “sacrificed” or lost) during initial separation steps, unlike protocols employed by existing DNA purification kit manufacturers. Outcomes result in higher quality DNA sequence data (i.e., higher sequencing coverage and higher sensitivity), thus providing robust information content, leading to higher confidence in organismal characterization. Syracuse Biolabs, Inc. (SBL), has teamed with scientists in the Forensic and National Security Sciences Institute (FNSSI) at Syracuse University to further improve and commercialize this novel DNA purification approach. The Phase I project clearly demonstrated the superiority of the Syracuse Method to currently available kits from Qiagen and Zymo Research. This Phase II project has five aims directed toward continued development of the method into a commercial product for fieldable cell/DNA purification modules of metagenomic samples. Our metagenomic DNA purification kit is also applicable to fields outside of the human microbiome research market, including forensic identification and geolocation of biological samples relevant to criminal and intelligence related activities, DNA based ecological research, plant and microbial based geosourcing, and defense/homeland security efforts (requiring DNA purification from environmental samples).

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2021–2025). Reported award amounts total $729,708. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.